APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Apremilast Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Apremilast Tablets Industry Growth and Trends Forecast to 2032

Report ID 173967020127 December 202592 pages

Choose your research edition.

Industry ResearchApremilast Tablets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Apremilast Tablets Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Apremilast Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Apremilast Tablets Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Apremilast Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Apremilast Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Apremilast Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Apremilast Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Apremilast Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Apremilast Tablets include CSPC Ouyi Pharmaceutical, Shanghai Modern Pharmaceutical, Qilu Pharmaceutical, Glenmark Pharmaceuticals and Amgen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Apremilast Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Apremilast Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Apremilast Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Apremilast Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Apremilast Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Apremilast Tablets Market by Company

CSPC Ouyi Pharmaceutical

Shanghai Modern Pharmaceutical

Qilu Pharmaceutical

Glenmark Pharmaceuticals

Amgen

Apremilast Tablets Segment by Type

10mg/Tablet

20mg/Tablet

30mg/Tablet

Apremilast Tablets Segment by Application

Hospital Pharmacy

Retail Pharmacy

Apremilast Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apremilast Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Apremilast Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apremilast Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Apremilast Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Apremilast Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg/Tablet Table 2. Major Company of 20mg/Tablet Table 3. Major Company of 30mg/Tablet Table 4. Global Apremilast Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 6. Global Apremilast Tablets Sales Market Share in Volume by Type (2021-2026) Table 7. Global Apremilast Tablets Sales by Type (2021-2026) & (US$ Million) Table 8. Global Apremilast Tablets Sales Market Share in Value by Type (2021-2026) Table 9. Global Apremilast Tablets Price by Type (2021-2026) & (US$/Unit) Table 10. Global Apremilast Tablets Sales by Type (2027-2032) & (K Units) Table 11. Global Apremilast Tablets Sales Market Share in Volume by Type (2027-2032) Table 12. Global Apremilast Tablets Sales by Type (2027-2032) & (US$ Million) Table 13. Global Apremilast Tablets Sales Market Share in Value by Type (2027-2032) Table 14. Global Apremilast Tablets Price by Type (2027-2032) & (US$/Unit) Table 15. North America Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 16. North America Apremilast Tablets Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 18. Europe Apremilast Tablets Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Apremilast Tablets Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 22. Latin America Apremilast Tablets Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Apremilast Tablets Sales by Type (2021-2026) & (US$ Million) Table 25. Apremilast Tablets Industry Trends Table 26. Apremilast Tablets Industry Drivers Table 27. Apremilast Tablets Industry Opportunities and Challenges Table 28. Apremilast Tablets Industry Restraints Table 29. Global Apremilast Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Apremilast Tablets Revenue Market Share by Company (2021-2026) Table 31. Global Apremilast Tablets Sales by Company (2021-2026) & (K Units) Table 32. Global Apremilast Tablets Sales Share by Company (2021-2026) Table 33. Global Apremilast Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Apremilast Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Apremilast Tablets Major Company Production Sites and Headquarters Table 36. Global Apremilast Tablets Company, Product Type & Application Table 37. Global Apremilast Tablets Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Apremilast Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Apremilast Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Apremilast Tablets Sales by Region (2021-2026) & (K Units) Table 42. Global Apremilast Tablets Sales Market Share in Volume by Region (2021-2026) Table 43. Global Apremilast Tablets Sales by Region (2021-2026) & (US$ Million) Table 44. Global Apremilast Tablets Sales Market Share in Value by Region (2021-2026) Table 45. Global Apremilast Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Apremilast Tablets Sales by Region (2027-2032) & (K Units) Table 47. Global Apremilast Tablets Sales Market Share in Volume by Region (2027-2032) Table 48. Global Apremilast Tablets Sales by Region (2027-2032) & (US$ Million) Table 49. Global Apremilast Tablets Sales Market Share in Value by Region (2027-2032) Table 50. Global Apremilast Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Apremilast Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 53. Global Apremilast Tablets Sales Market Share in Volume by Application (2021-2026) Table 54. Global Apremilast Tablets Sales by Application (2021-2026) & (US$ Million) Table 55. Global Apremilast Tablets Sales Market Share in Value by Application (2021-2026) Table 56. Global Apremilast Tablets Price by Application (2021-2026) & (US$/Unit) Table 57. Global Apremilast Tablets Sales by Application (2027-2032) & (K Units) Table 58. Global Apremilast Tablets Sales Market Share in Volume by Application (2027-2032) Table 59. Global Apremilast Tablets Sales by Application (2027-2032) & (US$ Million) Table 60. Global Apremilast Tablets Sales Market Share in Value by Application (2027-2032) Table 61. Global Apremilast Tablets Price by Application (2027-2032) & (US$/Unit) Table 62. North America Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 63. North America Apremilast Tablets Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 65. Europe Apremilast Tablets Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Apremilast Tablets Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 69. Latin America Apremilast Tablets Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Apremilast Tablets Sales by Application (2021-2026) & (US$ Million) Table 72. CSPC Ouyi Pharmaceutical Company Information Table 73. CSPC Ouyi Pharmaceutical Business Overview Table 74. CSPC Ouyi Pharmaceutical Apremilast Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. CSPC Ouyi Pharmaceutical Apremilast Tablets Product Portfolio Table 76. CSPC Ouyi Pharmaceutical Recent Development Table 77. Shanghai Modern Pharmaceutical Company Information Table 78. Shanghai Modern Pharmaceutical Business Overview Table 79. Shanghai Modern Pharmaceutical Apremilast Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Shanghai Modern Pharmaceutical Apremilast Tablets Product Portfolio Table 81. Shanghai Modern Pharmaceutical Recent Development Table 82. Qilu Pharmaceutical Company Information Table 83. Qilu Pharmaceutical Business Overview Table 84. Qilu Pharmaceutical Apremilast Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Qilu Pharmaceutical Apremilast Tablets Product Portfolio Table 86. Qilu Pharmaceutical Recent Development Table 87. Glenmark Pharmaceuticals Company Information Table 88. Glenmark Pharmaceuticals Business Overview Table 89. Glenmark Pharmaceuticals Apremilast Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Glenmark Pharmaceuticals Apremilast Tablets Product Portfolio Table 91. Glenmark Pharmaceuticals Recent Development Table 92. Amgen Company Information Table 93. Amgen Business Overview Table 94. Amgen Apremilast Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Amgen Apremilast Tablets Product Portfolio Table 96. Amgen Recent Development Table 97. North America Apremilast Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. North America Apremilast Tablets Sales by Country (2021-2026) & (K Units) Table 99. North America Apremilast Tablets Sales Market Share by Country (2021-2026) Table 100. North America Apremilast Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 101. North America Apremilast Tablets Sales Market Share Forecast by Country (2027-2032) Table 102. North America Apremilast Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Apremilast Tablets Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Apremilast Tablets Market Share by Country (2021-2026) Table 105. North America Apremilast Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Apremilast Tablets Market Share Forecast by Country (2027-2032) Table 107. Europe Apremilast Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Europe Apremilast Tablets Sales by Country (2021-2026) & (K Units) Table 109. Europe Apremilast Tablets Sales Market Share by Country (2021-2026) Table 110. Europe Apremilast Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 111. Europe Apremilast Tablets Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Apremilast Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Apremilast Tablets Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Apremilast Tablets Market Share by Country (2021-2026) Table 115. Europe Apremilast Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Apremilast Tablets Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Apremilast Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Apremilast Tablets Sales by Country (2021-2026) & (K Units) Table 119. Asia-Pacific Apremilast Tablets Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Apremilast Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 121. Asia-Pacific Apremilast Tablets Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Apremilast Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Apremilast Tablets Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Apremilast Tablets Market Share by Country (2021-2026) Table 125. Asia-Pacific Apremilast Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Apremilast Tablets Market Share Forecast by Country (2027-2032) Table 127. Latin America Apremilast Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Latin America Apremilast Tablets Sales by Country (2021-2026) & (K Units) Table 129. Latin America Apremilast Tablets Sales Market Share by Country (2021-2026) Table 130. Latin America Apremilast Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 131. Latin America Apremilast Tablets Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Apremilast Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Apremilast Tablets Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Apremilast Tablets Market Share by Country (2021-2026) Table 135. Latin America Apremilast Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Apremilast Tablets Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Apremilast Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Apremilast Tablets Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Apremilast Tablets Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Apremilast Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 141. Middle East and Africa Apremilast Tablets Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Apremilast Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Apremilast Tablets Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Apremilast Tablets Market Share by Country (2021-2026) Table 145. Middle East and Africa Apremilast Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Apremilast Tablets Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Apremilast Tablets Distributors List Table 150. Apremilast Tablets Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Apremilast Tablets Image Figure 2. Global Apremilast Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Apremilast Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Apremilast Tablets Sales (2021-2032) & (K Units) Figure 5. 10mg/Tablet Image Figure 6. Global 10mg/Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 20mg/Tablet Image Figure 8. Global 20mg/Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. 30mg/Tablet Image Figure 10. Global 30mg/Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Apremilast Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Apremilast Tablets Market Share by Type 2025 VS 2032 Figure 13. North America Apremilast Tablets Sales Market Share in Volume by Type in 2025 Figure 14. North America Apremilast Tablets Sales Market Share in Value by Type in 2025 Figure 15. Europe Apremilast Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Europe Apremilast Tablets Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Apremilast Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Apremilast Tablets Sales Market Share in Value by Type in 2025 Figure 19. Latin America Apremilast Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Apremilast Tablets Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Apremilast Tablets Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Apremilast Tablets Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Apremilast Tablets Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Pharmacy Image Figure 26. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Apremilast Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Apremilast Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Apremilast Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Apremilast Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Apremilast Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Apremilast Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Apremilast Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Apremilast Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Apremilast Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Apremilast Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Apremilast Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Apremilast Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Apremilast Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Apremilast Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Apremilast Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Apremilast Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Apremilast Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Apremilast Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Apremilast Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Apremilast Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Apremilast Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Apremilast Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Apremilast Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Apremilast Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Apremilast Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Apremilast Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Apremilast Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Apremilast Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Apremilast Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Apremilast Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Apremilast Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Apremilast Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Apremilast Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Apremilast Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/Tablet
  • 20mg/Tablet
  • 30mg/Tablet
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • CSPC Ouyi Pharmaceutical
  • Shanghai Modern Pharmaceutical
  • Qilu Pharmaceutical
  • Glenmark Pharmaceuticals
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Apremilast Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Apremilast Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Apremilast Tablets Market by Type
  6. 1.3.1 10mg/Tablet
  7. 1.3.2 20mg/Tablet
  8. 1.3.3 30mg/Tablet
  9. 1.4 Global Apremilast Tablets Market Size by Type
  10. 1.4.1 Global Apremilast Tablets Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Apremilast Tablets Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Apremilast Tablets Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Apremilast Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Apremilast Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Apremilast Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Apremilast Tablets Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Apremilast Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Apremilast Tablets Industry Trends
  2. 2.2 Apremilast Tablets Industry Drivers
  3. 2.3 Apremilast Tablets Industry Opportunities and Challenges
  4. 2.4 Apremilast Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Apremilast Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Apremilast Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Apremilast Tablets Price (2021-2026)
  4. 3.4 Global Apremilast Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Apremilast Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Apremilast Tablets Company, Product Type & Application
  7. 3.7 Global Apremilast Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Apremilast Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Apremilast Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Apremilast Tablets Tier 1, Tier 2, and Tier 3
4 Apremilast Tablets Regional Status and Outlook
  1. 4.1 Global Apremilast Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Apremilast Tablets Historic Market Size by Region
  3. 4.2.1 Global Apremilast Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Apremilast Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Apremilast Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Apremilast Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Apremilast Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Apremilast Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Apremilast Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Apremilast Tablets by Application
  1. 5.1 Apremilast Tablets Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Apremilast Tablets Market Size by Application
  5. 5.2.1 Global Apremilast Tablets Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Apremilast Tablets Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Apremilast Tablets Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Apremilast Tablets Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Apremilast Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Apremilast Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Apremilast Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Apremilast Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSPC Ouyi Pharmaceutical
  2. 6.1.1 CSPC Ouyi Pharmaceutical Company Information
  3. 6.1.2 CSPC Ouyi Pharmaceutical Business Overview
  4. 6.1.3 CSPC Ouyi Pharmaceutical Apremilast Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSPC Ouyi Pharmaceutical Apremilast Tablets Product Portfolio
  6. 6.1.5 CSPC Ouyi Pharmaceutical Recent Developments
  7. 6.2 Shanghai Modern Pharmaceutical
  8. 6.2.1 Shanghai Modern Pharmaceutical Company Information
  9. 6.2.2 Shanghai Modern Pharmaceutical Business Overview
  10. 6.2.3 Shanghai Modern Pharmaceutical Apremilast Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai Modern Pharmaceutical Apremilast Tablets Product Portfolio
  12. 6.2.5 Shanghai Modern Pharmaceutical Recent Developments
  13. 6.3 Qilu Pharmaceutical
  14. 6.3.1 Qilu Pharmaceutical Company Information
  15. 6.3.2 Qilu Pharmaceutical Business Overview
  16. 6.3.3 Qilu Pharmaceutical Apremilast Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qilu Pharmaceutical Apremilast Tablets Product Portfolio
  18. 6.3.5 Qilu Pharmaceutical Recent Developments
  19. 6.4 Glenmark Pharmaceuticals
  20. 6.4.1 Glenmark Pharmaceuticals Company Information
  21. 6.4.2 Glenmark Pharmaceuticals Business Overview
  22. 6.4.3 Glenmark Pharmaceuticals Apremilast Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Glenmark Pharmaceuticals Apremilast Tablets Product Portfolio
  24. 6.4.5 Glenmark Pharmaceuticals Recent Developments
  25. 6.5 Amgen
  26. 6.5.1 Amgen Company Information
  27. 6.5.2 Amgen Business Overview
  28. 6.5.3 Amgen Apremilast Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Amgen Apremilast Tablets Product Portfolio
  30. 6.5.5 Amgen Recent Developments
7 North America by Country
  1. 7.1 North America Apremilast Tablets Sales by Country
  2. 7.1.1 North America Apremilast Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Apremilast Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Apremilast Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Apremilast Tablets Market Size by Country
  6. 7.2.1 North America Apremilast Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Apremilast Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Apremilast Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Apremilast Tablets Sales by Country
  2. 8.1.1 Europe Apremilast Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Apremilast Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Apremilast Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Apremilast Tablets Market Size by Country
  6. 8.2.1 Europe Apremilast Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Apremilast Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Apremilast Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Apremilast Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Apremilast Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Apremilast Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Apremilast Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Apremilast Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Apremilast Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Apremilast Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Apremilast Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Apremilast Tablets Sales by Country
  2. 10.1.1 South America Apremilast Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Apremilast Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Apremilast Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Apremilast Tablets Market Size by Country
  6. 10.2.1 South America Apremilast Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Apremilast Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Apremilast Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Apremilast Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Apremilast Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Apremilast Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Apremilast Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Apremilast Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Apremilast Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Apremilast Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Apremilast Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Apremilast Tablets Value Chain Analysis
  2. 12.1.1 Apremilast Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Apremilast Tablets Production Mode & Process
  7. 12.2 Apremilast Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Apremilast Tablets Distributors
  10. 12.2.3 Apremilast Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst